Felvizumab

{{Short description|Monoclonal antibody}}

{{Drugbox

| Verifiedfields = changed

| verifiedrevid = 457123349

| image =

| type = mab

| mab_type = mab

| source = zu/o

| target = RSV

| tradename =

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number_Ref = {{cascite|correct|CAS}}

| CAS_number = 167747-20-8

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = W9ZA2K5Q83

| ATC_prefix = none

| ATC_suffix =

| PubChem =

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| KEGG_Ref = {{keggcite|correct|kegg}}

| KEGG = D04136

| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}

| ChemSpiderID = none

| chemical_formula =

| molecular_weight =

}}

Felvizumab is a humanized monoclonal antibody against respiratory syncytial virus.{{cite web | url = http://apps.who.int/medicinedocs/index/assoc/s14167e/s14167e.pdf | archive-url = https://web.archive.org/web/20120223171248/http://apps.who.int/medicinedocs/index/assoc/s14167e/s14167e.pdf | url-status = dead | archive-date = February 23, 2012 | title = WHO Drug Information }}{{cite book | vauthors = Milne GW |title=Drugs synonyms and properties |date=2018 |publisher=Routledge Revivals |location=London |isbn=978-1-351-78989-9 | chapter = 6591: Felvizumab | chapter-url = https://books.google.com/books?id=xUlaDwAAQBAJ&q=Felvizumab&pg=PT1145 }}